Remove Anatomy Remove Aortic Remove Stenosis
article thumbnail

Early experience with a novel transapical transcatheter aortic valve system in patients with severe aortic stenosis: a prospective, multicenter study

Frontiers in Cardiovascular Medicine

ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., Nanjing) to evaluate its safety and efficacy.Methods130 high risk patients with symptomatic severe AS from 11 institutions were treated with the novel Xcor system.

article thumbnail

Medtronic Announces FDA Approval of Newest-generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis

DAIC

milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. Circulation.

TAVR 111
article thumbnail

Abstract WP205: Association Between Bovine Aortic Arch Anatomy and Carotid Artery Stenosis

Stroke Journal

Background:The bovine aortic arch is a vascular variant in which the left common carotid artery originates from the brachiocephalic trunk rather than directly from the aortic arch. CTAs were reviewed to assess the carotid stenosis and the anatomy of the aortic arch. vs. N=16, 36.4%; p=0.030). vs. 70.0% [50.0-95.0];

Anatomy 40
article thumbnail

The feasibility of relaxation-enhanced angiography without contrast and triggering for preprocedural planning of transcatheter aortic valve implantation

Frontiers in Cardiovascular Medicine

Background Cardiovascular MRI is advantageous in transcatheter aortic valve implantation (TAVI) planning. Methods Thirty patients with severe aortic stenosis were prospectively enrolled. Both modalities showed similar aortic valve morphology and semi-quantitative valve calcification (all, p 's > 0.05).

article thumbnail

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). Poverall=0.522; 1 year: 10% versus 2.3%

article thumbnail

New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance

DAIC

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. 2023, September 6).

TAVR 111
article thumbnail

What Is TAVR? A Closer Look at Transcatheter Aortic Valve Replacement

AMS Cardiology

If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. Understanding Aortic Stenosis The aortic valve regulates blood flow from your heart’s main pumping chamber to the rest of your body. In aortic stenosis, the valve leaflets stiffen and narrow, restricting blood flow.